Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalin Arends

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Analytical Chemistry|December 20, 2012
Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factorHendrik Neubert, David Muirhead, Musarat Kabir, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 16, 2025
From In Vitro Efficacy to Long-Term HbA1c Response for GLP-1R/GlucagonR Agonism Using the 4GI-HbA1c Systems ModelRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2021
A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP-1 dual agonistRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
British Journal of Pharmacology|February 25, 2024
Characterisation of cotadutide's dual GLP-1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology modelRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
British Journal of Clinical Pharmacology|November 3, 2011
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjectsGai Ling Li, Helen Winter, Rosalin Arends, et al.
Clinical Pharmacokinetics|October 7, 2010
Pharmacokinetic and pharmacodynamic perspectives on the clinical drug development of panitumumabBing-Bing Yang, Peggy Lum, Alin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancerEric K Rowinsky, Garry H Schwartz, Jared A Gollob, et al.
Clinical Pharmacology and Therapeutics|July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 InfectionRachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Analytical Chemistry|December 20, 2012
Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factorHendrik Neubert, David Muirhead, Musarat Kabir, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 16, 2025
From In Vitro Efficacy to Long-Term HbA1c Response for GLP-1R/GlucagonR Agonism Using the 4GI-HbA1c Systems ModelRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2021
A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP-1 dual agonistRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
British Journal of Pharmacology|February 25, 2024
Characterisation of cotadutide's dual GLP-1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology modelRolien Bosch, Marcella Petrone, Rosalin Arends, et al.
British Journal of Clinical Pharmacology|November 3, 2011
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjectsGai Ling Li, Helen Winter, Rosalin Arends, et al.
Clinical Pharmacokinetics|October 7, 2010
Pharmacokinetic and pharmacodynamic perspectives on the clinical drug development of panitumumabBing-Bing Yang, Peggy Lum, Alin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancerEric K Rowinsky, Garry H Schwartz, Jared A Gollob, et al.
Clinical Pharmacology and Therapeutics|July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 InfectionRachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
Pageof 1